Thank you for subscribing.

Please check your email to confirm.

Unsubscribe success..

You already subscribed and confirmed.

Please check your email.

You already subscribed.

Please check your email to confirm.

Alibaba and Meituan Compete with Veggie-selling Startup Meicai
Huawei, the second-largest smartphone vendor, is better equipped than most Chinese firms to weather this storm. However, it may be in deep trouble now that the UK-based ARM has decided to stop working with Huawei.
Shanghai Cell Therapy Group has completed CNY 650 million -the equivalent of approximately USD 95 million,- in Series C2 financing at an undisclosed time.
The registered capital of the company is CNY 474 million, and the major shareholder is Xpeng Motors, with a shareholding of 73.84%.



EqualOcean is a leading industrial tech media and investment research company that focuses on technological and industrial innovation in China.

We aim to assist Chinese entrepreneurial enterprises to break into the global market and provide overseas investors, VCs, and enterprises with a deeper understanding of China's business environment and to seize opportunities in China.

Join over 800,000 of your peers